Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)

v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
Common Shares [Member]
Shelf Offering
Common Shares [Member]
Additional Paid-in Capital [Member]
Shelf Offering
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Loss [Member]
Shelf Offering
Accumulated Other Comprehensive Loss [Member]
Accumulated Deficit [Member]
Shelf Offering
Accumulated Deficit [Member]
Convertible Preferred Stock [Member]
Shelf Offering
Convertible Preferred Stock [Member]
Shelf Offering
Total
Balance at Dec. 31, 2018       $ 179,503,000   $ (45,000)   $ (175,640,000)   $ 0   $ 3,818,000
Balance (in shares) at Dec. 31, 2018   769,890                    
Release of vested restricted common stock       (65,000)   0   0   0   (65,000)
Release of vested restricted common stock (in shares)   6,193                    
Issuance of warrants for common stock       0   0   0   0   0
Currency translation adjustment       0   (11,000)   0   0   (11,000)
Net loss       0   0   (2,565,000)   0   (2,565,000)
Balance at Mar. 31, 2019   $ 0   179,438,000   (56,000)   (178,205,000)   $ 0   1,177,000
Balance (in shares) at Mar. 31, 2019   776,083               0    
Balance at Dec. 31, 2018       179,503,000   (45,000)   (175,640,000)   $ 0   3,818,000
Balance (in shares) at Dec. 31, 2018   769,890                    
Deemed dividend from warrant repricing                       0
Convertible/Accretion preferred stock dividend           0   0        
Foreign currency translation adjustment                       (13,000)
Net loss                       (8,097,000)
Balance at Sep. 30, 2019       184,702,000   (58,000)   (183,737,000)   $ 497,000   907,000
Balance (in shares) at Sep. 30, 2019   1,024,198               250,000    
Balance at Mar. 31, 2019   $ 0   179,438,000   (56,000)   (178,205,000)   $ 0   1,177,000
Balance (in shares) at Mar. 31, 2019   776,083               0    
Issuance of common stock and warrants, net of offering costs       4,664,000   0   0   $ 0   4,664,000
Issuance of common stock and warrants, net of offering costs (in shares)   203,786                    
Proceeds from issuance of preferred stock and common stock warrants, net of issuance costs       200,000   0   0   $ 720,000   200,000
Proceeds from issuance of preferred stock and common stock warrants, net of issuance costs (in shares)                   250,000    
Convertible/Accretion preferred stock dividend       (16,000)   0   0   $ 16,000   (16,000)
Issuance of warrants for common stock (in shares)   0                    
Fair value of derivative liability in connection with issuance of preferred stock       0   0   0   (216,000)   0
Issuance of warrants for common stock in connection with preferred stock offering   $ 0   43,000   0   0   $ (43,000)   43,000
Issuance of warrants for common stock in connection with preferred stock offering (in shares)                   0    
Issuance of common stock for services       234,000   0   0   $ 0   234,000
Issuance of common stock for services (in shares)   8,077                    
Currency translation adjustment       0   (2,000)   0   0   (2,000)
Net loss       0   0   (2,824,000)   0   (2,824,000)
Balance at Jun. 30, 2019       184,563,000   (58,000)   (181,029,000)   $ 477,000   3,476,000
Balance (in shares) at Jun. 30, 2019   987,946               250,000    
Convertible/Accretion preferred stock dividend       (20,000)           $ 20,000   (20,000)
Stock-based compensation       10,000   0   0   0   10,000
Stock-based compensation (in shares)   11,000                    
Release of vested restricted common stock       (22,000)   0   0   0   (22,000)
Release of vested restricted common stock (in shares)   20,514                    
Foreign currency translation adjustment                       0
Issuance of warrants for common stock       46,000   0   0   0   46,000
Change in fair value of common stock warrants upon repricing       46,000   0   0   0   46,000
Issuance of common stock upon warrant exercise       67,000   0   0   0   67,000
Issuance of common stock upon warrant exercise   4,176                    
Issuance of common stock for services       12,000   0   0   0   12,000
Issuance of common stock for services (in shares)   563                    
Net loss       0   0   (2,708,000)   0   (2,708,000)
Balance at Sep. 30, 2019       184,702,000   (58,000)   (183,737,000)   $ 497,000   907,000
Balance (in shares) at Sep. 30, 2019   1,024,198               250,000    
Balance at Dec. 31, 2019   $ 0   188,320,000   (48,000)   (187,678,000)   $ 517,000   594,000 [1]
Balance (in shares) at Dec. 31, 2019   1,245,238               250,000    
Issuance of common stock and warrants, net of offering costs   $ 0   725,000   0   0   $ 0   725,000
Issuance of common stock and warrants, net of offering costs (in shares)   91,062               0    
Issuance of common stock in connection with notes payable   $ 0   4,000   0   0   $ 0   4,000
Issuance of common stock in connection with notes payable (in shares)   500               0    
Issuance of warrants in connection with convertible notes payable   $ 0   630,000   0   0   $ 0   630,000
Convertible/Accretion preferred stock dividend   0   (20,000)   0   0   20,000   (20,000)
Stock-based compensation   $ 0   75,000   0   0   $ 0   75,000
Stock-based compensation (in shares)   2,000               0    
Restricted stock awards cancelled   $ 0   0   0   0   $ 0   0
Restricted stock awards cancelled (in shares)   (550)               0    
Release of vested restricted common stock   $ 0   0   0   0   $ 0   0
Release of vested restricted common stock (in shares)   353                    
Net loss   $ 0   0   0   (2,680,000)   0   (2,680,000)
Balance at Mar. 31, 2020   $ 0   189,734,000   (48,000)   (190,358,000)   $ 537,000   (672,000)
Balance (in shares) at Mar. 31, 2020   1,338,603               250,000    
Balance at Dec. 31, 2019   $ 0   188,320,000   (48,000)   (187,678,000)   $ 517,000   594,000 [1]
Balance (in shares) at Dec. 31, 2019   1,245,238               250,000    
Deemed dividend from warrant repricing                       (134,000)
Convertible/Accretion preferred stock dividend   $ 0       0   0        
Foreign currency translation adjustment                       0
Net loss                       (9,068,000)
Balance at Sep. 30, 2020   $ 1,000   206,030,000   0   (196,746,000)   $ 577,000   9,285,000
Balance (in shares) at Sep. 30, 2020   7,822,375               250,000    
Balance at Mar. 31, 2020   $ 0   189,734,000   (48,000)   (190,358,000)   $ 537,000   (672,000)
Balance (in shares) at Mar. 31, 2020   1,338,603               250,000    
Issuance of common stock and warrants, net of offering costs $ 1,000   $ 9,957,000   $ 0   $ 0   $ 0   $ 9,958,000  
Issuance of common stock and warrants, net of offering costs (in shares) 4,315,000               0      
Issuance of common stock in connection with settlements   $ 0   135,000   0   0   $ 0   135,000
Issuance of common stock in connection with settlements (in shares)   60,250               0    
Deemed dividend from warrant down-round provision   $ 0   (134,000)   0   0   $ 0   (134,000)
Deemed dividend from warrant repricing   0   134,000   0   0   0   134,000
Convertible/Accretion preferred stock dividend   0   (20,000)           20,000   (20,000)
Stock-based compensation   $ 0   72,000   0   0   $ 0   72,000
Stock-based compensation (in shares)   2,000               0    
Restricted stock awards cancelled   $ 0   0   0   0   $ 0   0
Restricted stock awards cancelled (in shares)   (2,500)               0    
Issuance of common stock, prefunded warrants and warrants, net of public offering costs   $ 0   5,515,000   0   0   $ 0   5,515,000
Issuance of common stock, prefunded warrants and warrants, net of public offering costs (in shares)   1,525,000               0    
Proceeds from the exercise of prefunded warrants and common stock warrants   $ 0   37,000   0   0   $ 0   37,000
Proceeds from the exercise of prefunded warrants and common stock warrants (in shares)   485,000               0    
Gain on foreign currency translation from closure of subsidiary   $ 0   0   48,000   0   $ 0   48,000
Net loss   0   0   0   (3,398,000)   0   (3,398,000)
Balance at Jun. 30, 2020   $ 1,000   205,430,000   0   (193,756,000)   $ 557,000   11,675,000
Balance (in shares) at Jun. 30, 2020   7,723,353               250,000    
June 2020 shelf offering - issuance costs   $ 0   (42,000)   0   0   $ 0   (42,000)
Deemed dividend from warrant repricing                       0
Convertible/Accretion preferred stock dividend   0   (20,000)   0   0   20,000   (20,000)
Stock-based compensation   $ 0   662,000   0   0   0   662,000
Stock-based compensation (in shares)   98,669                    
Release of vested restricted common stock   $ 0   0   0   0   0   0
Release of vested restricted common stock (in shares)   353                    
Foreign currency translation adjustment                       0
Net loss   $ 0   0   0   (2,990,000)   0   (2,990,000)
Balance at Sep. 30, 2020   $ 1,000   $ 206,030,000   $ 0   $ (196,746,000)   $ 577,000   $ 9,285,000
Balance (in shares) at Sep. 30, 2020   7,822,375               250,000    
[1] The condensed consolidated balance sheet as of December 31, 2019 was derived from the audited consolidated balance sheet as of that date.